[1]
|
Daiger, S.P., Sullivan, L.S. and Bowne, S.J. (2013) Genes and Mutations Causing Retinitis Pigmentosa. Clinical Genetics, 84, 132-141. https://doi.org/10.1111/cge.12203
|
[2]
|
Lee, T.J., Hwang, J.C., Chen, R.W.S., et al. (2014) The Role of Fundus Autofluorescence in Late-Onset Retinitis Pigmentosa (LORP) Diagnosis. Ophthalmic Genetics, 35, 170-179. https://doi.org/10.3109/13816810.2013.800891
|
[3]
|
Hartong, D.T., Berson, E.L. and Dryja, T.P. (2006) Retinitis Pigmentosa. The Lancet, 368, 1795-1809.
|
[4]
|
Meirelles, S.H.S, Barreto, A.S., Buscacio, E.S., et al. (2015) Retinitis Pigmentosa with Concomitant Essential Iris Atrophy and Glaucoma—Case Report. Clinical Ophthalmology (Auckland, NZ), 9, 2139.
https://doi.org/10.2147/OPTH.S75384
|
[5]
|
Gauvin, M., Chakor, H., Koenekoop, R.K., et al. (2016) Witnessing the First Sign of Retinitis Pigmentosa Onset in the Allegedly Normal Eye of a Case of Unilateral RP: A 30-Year Follow-Up. Documenta Ophthalmo-logica, 132, 213-229. https://doi.org/10.1007/s10633-016-9537-y
|
[6]
|
Wong, F. (1997) Investigating Retinitis Pigmentosa: A La-boratory Scientist’s Perspective. Progress in Retinal and Eye Research, 16, 353-373.
|
[7]
|
Ghazi, N.G., Abboud, E.B., Nowilaty, S.R., et al. (2016) Treatment of Retinitis Pigmentosa Due to MERTK Mutations by Ocular Subretinal Injection of Adeno-Associated Virus Gene Vector: Results of a Phase I Trial. Human Genetics, 135, 327-343. https://doi.org/10.1007/s00439-016-1637-y
|
[8]
|
Ghodasra, D.H., Chen, A., Arevalo, J.F., et al. (2016) Worldwide Argus II implantation: Recommendations to Optimize Patient Outcomes. BMC ophthalmology, 16, 1.
|
[9]
|
Radtke, N.D. (1992) Meeting the Needs of the 21st Century—Through Programs of Awareness and Ed-ucation. The Journal of the Kentucky Medical Association, 90, 527.
|